Evidence map›Paper›PMID 27911441›Full record

ArticleCell death and differentiation2017

SIRT1 protects the heart from ER stress-induced cell death through eIF2α deacetylation.

Alexandre Prola, Julie Pires Da Silva, Arnaud Guilbert, Lola Lecru, Jérôme Piquereau, Maxance Ribeiro, Philippe Mateo, Mélanie Gressette, Dominique Fortin, Céline Boursier and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell death and differentiation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 134 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
134citing papers in PubMed, 1 pooled it
9.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

134 citing papers in PubMed, 1 synthesis or guideline pooled it, 214 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. The Role of NADAmerican journal of cardiovascular drugs : drugs, devices, and other interventions · 2025
    Review
  20. Article

74 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 3 countries.

Alexandre ProlaUMR-S 1180, INSERM, Univ Paris-Sud, Université Paris-Saclay, Châtenay-Malabry, France.
Julie Pires Da SilvaUMR-S 1180, INSERM, Univ Paris-Sud, Université Paris-Saclay, Châtenay-Malabry, France.
Arnaud GuilbertUMR-S 1180, INSERM, Univ Paris-Sud, Université Paris-Saclay, Châtenay-Malabry, France.
Lola LecruUMR-S 1014, INSERM, Univ Paris-Sud, Université Paris-Saclay, Hôpital Paul Brousse, Villejuif, France.
Jérôme PiquereauUMR-S 1180, INSERM, Univ Paris-Sud, Université Paris-Saclay, Châtenay-Malabry, France.
Maxance RibeiroUMR-S 1180, INSERM, Univ Paris-Sud, Université Paris-Saclay, Châtenay-Malabry, France.
Philippe MateoUMR-S 1180, INSERM, Univ Paris-Sud, Université Paris-Saclay, Châtenay-Malabry, France.
Mélanie GressetteUMR-S 1180, INSERM, Univ Paris-Sud, Université Paris-Saclay, Châtenay-Malabry, France.
Dominique FortinUMR-S 1180, INSERM, Univ Paris-Sud, Université Paris-Saclay, Châtenay-Malabry, France.
Céline BoursierInstitut Paris-Sud d'Innovation Thérapeutique, Univ Paris-Sud, Université Paris-Saclay, Chatenay-Malabry, France.
Cindy GallerneUMR-S 1014, INSERM, Univ Paris-Sud, Université Paris-Saclay, Hôpital Paul Brousse, Villejuif, France.
Anaïs CaillardUMR-S 942, INSERM, Univ Denis Diderot, Hôpital Lariboisière, Paris, France.
Jane-Lise SamuelUMR-S 942, INSERM, Univ Denis Diderot, Hôpital Lariboisière, Paris, France.
Hélène FrançoisUMR-S 1014, INSERM, Univ Paris-Sud, Université Paris-Saclay, Hôpital Paul Brousse, Villejuif, France.
David A SinclairGlenn Labs for the Biological Mechanisms of Aging, Department of Genetics, Harvard Medical School, Boston, MA, USA.
Pierre EidUMR-S 1014, INSERM, Univ Paris-Sud, Université Paris-Saclay, Hôpital Paul Brousse, Villejuif, France.
Renée Ventura-ClapierUMR-S 1180, INSERM, Univ Paris-Sud, Université Paris-Saclay, Châtenay-Malabry, France.
Anne GarnierUMR-S 1180, INSERM, Univ Paris-Sud, Université Paris-Saclay, Châtenay-Malabry, France.
Christophe LemaireUMR-S 1180, INSERM, Univ Paris-Sud, Université Paris-Saclay, Châtenay-Malabry, France.
Université Paris-Saclay · FRInserm · FRHarvard University · USHôpital Lariboisière · FR

Funding

SIRT as a regulator of health and lifespan of mammalsR01AG028730 · NIA · HARVARD MEDICAL SCHOOL · PI SINCLAIR, DAVID A. · 2007 to 2011
$1.7M
NIA NIH HHS R01 AG028730
6 · The paper itself

Abstract

Over the past decade, endoplasmic reticulum (ER) stress has emerged as an important mechanism involved in the pathogenesis of cardiovascular diseases including heart failure. Cardiac therapy based on ER stress modulation is viewed as a promising avenue toward effective therapies for the diseased heart. Here, we tested whether sirtuin-1 (SIRT1), a NAD

Indexed as

ApoptosisEndoplasmic Reticulum StressAcetylationActivating Transcription Factor 6AnimalsCarbazolesCell LineEndoplasmic Reticulum Chaperone BiPEukaryotic Initiation Factor-2Heat-Shock ProteinsMembrane GlycoproteinsMembrane ProteinsMiceMice, Inbred C57BLMice, KnockoutMutagenesis, Site-Directed6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamideActivating Transcription Factor 6Atf6 protein, mouseCarbazolesEndoplasmic Reticulum Chaperone BiPendoplasminErn2 protein, mouseEukaryotic Initiation Factor-2Heat-Shock ProteinsMembrane GlycoproteinsMembrane ProteinsProtein Serine-Threonine KinasesSirtuin 1Tunicamycin

Identifiers

PMID27911441
PMCPMC5299716
OpenAlexW2559137999

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.